Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to confirm device use safety and effectiveness of the Eximis CS (Contained Segmentation) System in actual use by representative users, use, and use environments as required for regulatory agency clearance for commercial use.


Clinical Trial Description

This is a prospective, multi-center, single-arm study to confirm device use safety and effectiveness in an actual use setting when utilized by gynecological surgeons during surgery for containment, segmentation and extraction of uterine tissue in pre-menopausal women undergoing laparoscopic hysterectomy or myomectomy for non-cancer indications. ;


Study Design


Related Conditions & MeSH terms

  • Laparoscopic Gynecological Surgery

NCT number NCT04799210
Study type Interventional
Source Eximis Surgical
Contact
Status Terminated
Phase N/A
Start date September 16, 2021
Completion date December 13, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03845608 - Analgesic Effect of Pulmonary Recruitment and Intraperitoneal Hydrocortisone in Laparoscopic Gynecological Surgery Phase 4
Completed NCT05489796 - Bellomic PCA in Laparoscopic Gynecologic Surgery N/A
Recruiting NCT05936671 - EEG and ANI Guided Anesthesia and Quality of Recovery N/A
Withdrawn NCT01955798 - Direct Trocar Entry Versus Veress Needle Entry in Laparoscopic Gynecological Surgery N/A